These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

38 related articles for article (PubMed ID: 2381159)

  • 1. [Haloperidol].
    Blumenberg D
    Krankenpfl J; 1990; 28(7-8):396-9. PubMed ID: 2381159
    [No Abstract]   [Full Text] [Related]  

  • 2. Attenuation by pergolide of haloperidol-induced striatal dopamine receptor density.
    Koller WC
    J Clin Psychopharmacol; 1984 Dec; 4(6):343-5. PubMed ID: 6512004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presynaptic dopamine receptors in striatal nerve endings: absence of haloperidol-induced supersensitivity.
    Raiteri M; Cerrito F; Casazza G; Levi G
    Adv Biochem Psychopharmacol; 1980; 24():37-43. PubMed ID: 7405669
    [No Abstract]   [Full Text] [Related]  

  • 4. [Difference in mechanism of action of sulpiride and haloperidol on dopamine brain turnover].
    Imazu Y; Kobayashi K; Shomori T
    Seishin Shinkeigaku Zasshi; 1988; 90(10):845-52. PubMed ID: 3251268
    [No Abstract]   [Full Text] [Related]  

  • 5. Sensitive periods for the effect of haloperidol on development of striatal dopamine receptors.
    Rosengarten H; Friedman E; Friedhoff AJ
    Birth Defects Orig Artic Ser; 1983; 19(4):511-3. PubMed ID: 6871420
    [No Abstract]   [Full Text] [Related]  

  • 6. Chronic haloperidol does not increase specific dopamine receptor binding in rat frontal cortex.
    Meller E; Bohmaker K; Rosengarten H; Friedhoff AJ
    Res Commun Chem Pathol Pharmacol; 1982 Sep; 37(3):323-32. PubMed ID: 7178646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in dopamine receptors: effect of lesion and haloperidol treatment.
    Goldstein M; Lew JY; Asano T; Ueta K
    Commun Psychopharmacol; 1980; 4(1):21-5. PubMed ID: 6105037
    [No Abstract]   [Full Text] [Related]  

  • 8. Further observations on vesicourethral dopamine receptors--a urodynamic study with haloperidol.
    Vaidyanathan S; Rao MS; Bapna BC; Sharma PL; Chary KS; Swamy RP
    Ann Clin Res; 1980 Apr; 12(2):49-51. PubMed ID: 7447363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of repeated haloperidol and apomorphine administration on the development of tolerance for catalepsy and dopamine receptor hypersensitivity in mice].
    Zharkovskiĭ AM; Matvienko OA; Nurk AM
    Biull Eksp Biol Med; 1984 Oct; 98(10):444-6. PubMed ID: 6541951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors contributing to the up regulation of dopaminergic receptors by chronic haloperidol.
    Schweitzer JW; Schwartz R; Friedhoff AJ
    Res Commun Chem Pathol Pharmacol; 1982 Oct; 38(1):21-30. PubMed ID: 7146618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of haloperidol on ventilatory responses to dopamine in man.
    Bainbridge CW; Heistad DD
    J Pharmacol Exp Ther; 1980 Apr; 213(1):13-7. PubMed ID: 7359361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Continuous suppression of methamphetamine-induced supersensitivity by chronic haloperidol administration].
    Kashihara K; Fujiwara Y; Sato M
    Seishin Shinkeigaku Zasshi; 1984; 86(11):928-32. PubMed ID: 6543469
    [No Abstract]   [Full Text] [Related]  

  • 13. [Role of serotonin and dopamine receptors in the mechanism of action of haloperidol and pirenperone].
    Maĭmets MO; Vasar EE; Nurk AM; Allikmets LKh
    Farmakol Toksikol; 1985; 48(2):15-8. PubMed ID: 3996566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Action of haloperidol on the ultrastructure of areas of the dopaminergic system of the brain].
    Klintsova AIu; Uranova NA; Schenk H; Hasselhorst U
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1987; 87(7):1028-31. PubMed ID: 3673382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of long-term treatment with haloperidol and sulpiride on different types of dopaminergic receptors.
    Trabucchi M; Memo M; Battaini F; Reggiani A; Spano PF
    Adv Biochem Psychopharmacol; 1980; 24():275-81. PubMed ID: 7405667
    [No Abstract]   [Full Text] [Related]  

  • 16. Pre- and postsynaptic mechanisms in haloperidol-induced sensitization to dopaminergic agonists.
    Muller P; Svensson TH; Carlsson A
    Adv Biochem Psychopharmacol; 1980; 24():69-74. PubMed ID: 6105807
    [No Abstract]   [Full Text] [Related]  

  • 17. [Supersensitivity of isolated rat vas deferens to dopamine in animals pretreated wit reserpine and haloperidol (author's transl)].
    Alloza JL; Salva JA
    Arch Farmacol Toxicol; 1980 Aug; 6(2):119-30. PubMed ID: 7469495
    [No Abstract]   [Full Text] [Related]  

  • 18. [The pharmacokinetic effect of haloperidol on DA receptors].
    Giorgobiani IB; Kitiashvili SA
    Georgian Med News; 2005 Mar; (120):68-70. PubMed ID: 15855705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neuroleptic-induced dopaminergic supersensitivity following intermittent and continuous haloperidol administrations in rats].
    Sato M; Kashihara K; Harada T
    Seishin Shinkeigaku Zasshi; 1984; 86(10):841-4. PubMed ID: 6522512
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of haloperidol on the chemoexcitability of identified giant neurons of mollusks].
    Bender KI; Petrov NV
    Farmakol Toksikol; 1983; 46(1):30-4. PubMed ID: 6825815
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.